Etiologic factors that can cause chronic obstructive pulmonary disease (COPD) include air pollution, secondhand smoke, chemicals, dust, fumes, and the genetic condition Alpha-1 deficiency. Signs and symptoms include smoking depressing scavenger cells and ciliary function, occupational and outdoor air pollution contributing to development. Medical management includes bronchodilators to relieve bronchospasm, corticosteroids for short-term improvement, and other medications like antibiotics and oxygen therapy. Nursing management focuses on assessing exposure risks, medical history, signs/symptoms, knowledge, and vital signs/breath sounds.
Etiologic factors that can cause chronic obstructive pulmonary disease (COPD) include air pollution, secondhand smoke, chemicals, dust, fumes, and the genetic condition Alpha-1 deficiency. Signs and symptoms include smoking depressing scavenger cells and ciliary function, occupational and outdoor air pollution contributing to development. Medical management includes bronchodilators to relieve bronchospasm, corticosteroids for short-term improvement, and other medications like antibiotics and oxygen therapy. Nursing management focuses on assessing exposure risks, medical history, signs/symptoms, knowledge, and vital signs/breath sounds.
Etiologic factors that can cause chronic obstructive pulmonary disease (COPD) include air pollution, secondhand smoke, chemicals, dust, fumes, and the genetic condition Alpha-1 deficiency. Signs and symptoms include smoking depressing scavenger cells and ciliary function, occupational and outdoor air pollution contributing to development. Medical management includes bronchodilators to relieve bronchospasm, corticosteroids for short-term improvement, and other medications like antibiotics and oxygen therapy. Nursing management focuses on assessing exposure risks, medical history, signs/symptoms, knowledge, and vital signs/breath sounds.
Etiologic factors that can cause chronic obstructive pulmonary disease (COPD) include air pollution, secondhand smoke, chemicals, dust, fumes, and the genetic condition Alpha-1 deficiency. Signs and symptoms include smoking depressing scavenger cells and ciliary function, occupational and outdoor air pollution contributing to development. Medical management includes bronchodilators to relieve bronchospasm, corticosteroids for short-term improvement, and other medications like antibiotics and oxygen therapy. Nursing management focuses on assessing exposure risks, medical history, signs/symptoms, knowledge, and vital signs/breath sounds.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 1
Etiologic Factors:
- Exposure to air pollution
- Breathing secondhand smoke Medical Management: - Working with chemicals, dust and fumes - Bronchodilators. Bronchodilators relieve - A genetic condition called Alpha-1 bronchospasm by altering the smooth muscle deficiency tone and reduce airway obstruction by allowing increased oxygen distribution throughout the lungs and improving alveolar ventilation. - Corticosteroids. A short trial course of oral Signs and Symptoms: corticosteroids may be prescribed for patients to determine whether pulmonary function Smoking depresses the activity of improves and symptoms decrease. scavenger cells and affects the - Other medications. Other pharmacologic respiratory tract’s ciliary cleansing treatments that may be used in COPD include mechanism. alpha1-antitrypsin augmentation therapy, Occupational exposure. Prolonged antibiotic agents, mucolytic agents, antitussive and intense exposure to agents, vasodilators, and narcotics. occupational dust and chemicals, indoor air pollution, and outdoor air Management of Exacerbations pollution all contribute to the - Optimization of bronchodilator medications is development of COPD. first-line therapy and involves identifying the Genetic abnormalities. The well- best medications or combinations of documented genetic risk factor is a medications taken on a regular schedule for a deficiency of alpha1- antitrypsin, an specific patient. enzyme inhibitor that protects the - Hospitalization. Indications for hospitalization lung parenchyma from injury. for acute exacerbation of COPD include severe dyspnea that does not respond to initial therapy, confusion or lethargy, respiratory muscle fatigue, paradoxical chest wall movement, and peripheral edema. Nursing Management: - Oxygen therapy. Upon arrival of the patient in Assess patient’s exposure to risk the emergency room, supplemental oxygen factors. therapy is administered and rapid assessment Assess the patient’s past and present is performed to determine if the exacerbation medical history. is life-threatening. Assess the signs and symptoms of - Antibiotics. Antibiotics have been shown to be COPD and their severity. of some benefit to patients with increased Assess the patient’s knowledge of the dyspnea, increased sputum production, and disease. increased sputum purulence. Assess the patient’s vital signs. Assess breath sounds and pattern.